Download Free Sample

Amyloidosis Therapeutics Market, Global Outlook and Forecast 2023-2030

The global Amyloidosis Therapeutics market was valued at US$ 4720.2 million in 2022 and is projected to reach US$ 6652.5 million by 2029, at a CAGR of 5.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Amyloidosis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amyloidosis Therapeutics. This report contains market size and forecasts of Amyloidosis Therapeutics in global, including the following market information:

• Global Amyloidosis Therapeutics Market Revenue, 2018-2023, 2024-2030, ($ millions)
• Global Amyloidosis Therapeutics Market Sales, 2018-2023, 2024-2030, (K Pcs)
• Global top five Amyloidosis Therapeutics companies in 2022 (%)

The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
AG-10 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Amyloidosis Therapeutics include Pfizer Inc., ProteoTech, Inc., Alnylam Pharmaceuticals, Inc., Arcturus Therapeutics, Inc, Bellus Health Inc., Bsim2, Celgene Corporation, Millennium Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Amyloidosis Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Amyloidosis Therapeutics Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Amyloidosis Therapeutics Market Segment Percentages, by Type, 2022 (%)

• AG-10
• ALN-ANG
• ALN-TTRsc02
• CAEL-101
• Canakinumab
• Others

Global Amyloidosis Therapeutics Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Amyloidosis Therapeutics Market Segment Percentages, by Application, 2022 (%)

• AL Amyloidosis
• AA Amyloidoses
• ATTR Amyloidoses
• Others

Global Amyloidosis Therapeutics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Amyloidosis Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Amyloidosis Therapeutics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Amyloidosis Therapeutics revenues share in global market, 2022 (%)
Key companies Amyloidosis Therapeutics sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Amyloidosis Therapeutics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:

• Pfizer Inc.
• ProteoTech, Inc.
• Alnylam Pharmaceuticals, Inc.
• Arcturus Therapeutics, Inc
• Bellus Health Inc.
• Bsim2
• Celgene Corporation
• Millennium Pharmaceuticals, Inc.
• Onyx Pharmaceuticals, Inc.
• GlaxoSmithKline Plc
• Isis Pharmaceuticals, Inc.
• Prothena Corporation Plc
• SOM Innovation Biotech SL

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Amyloidosis Therapeutics, market overview.
• Chapter 2: Global Amyloidosis Therapeutics market size in revenue and volume.
• Chapter 3: Detailed analysis of Amyloidosis Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Amyloidosis Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: Global Amyloidosis Therapeutics capacity by region & country.
• Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
• Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
• Chapter 11: The main points and conclusions of the report.